Pharmaceutical Contract Manufacturing Market | Acumen Research and Consulting

CHAPTER 1. Industry Overview of Pharmaceutical Contract Manufacturing Market

1.1. Definition and Scope

1.1.1. Definition of Pharmaceutical Contract Manufacturing

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Pharmaceutical Contract Manufacturing Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Pharmaceutical Contract Manufacturing Market By Services

1.2.3. Pharmaceutical Contract Manufacturing Market By End-user

1.2.4. Pharmaceutical Contract Manufacturing Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data End-user

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Pharmaceutical Contract Manufacturing Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Pharmaceutical Contract Manufacturing Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Price Trend of Key Raw Materials

3.8.1. Raw Material Suppliers

3.8.2. Proportion of Manufacturing Cost Structure

3.8.2.1. Raw Material

3.8.2.2. Labor Cost

3.8.2.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Pharmaceutical Contract Manufacturing Market By Services

5.1. Introduction

5.2. Pharmaceutical Contract Manufacturing Revenue By Services

5.2.1. Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast, By Services, 2020-2032

5.2.2. Pharmaceutical Manufacturing Services

5.2.2.1. Pharmaceutical Manufacturing Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.2. Pharmaceutical API Manufacturing Services

5.2.2.2.1. Pharmaceutical API Manufacturing Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3. Pharmaceutical FDF Manufacturing Services

5.2.2.3.1. Pharmaceutical FDF Manufacturing Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3.2. Tablet manufacturing services

5.2.2.3.2.1. Tablet manufacturing services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3.3. Parenteral/injectable manufacturing services

5.2.2.3.3.1. Parenteral/injectable manufacturing services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3.4. Capsule manufacturing services

5.2.2.3.4.1. Capsule manufacturing services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3.5. Semi-solid manufacturing services

5.2.2.3.5.1. Semi-solid manufacturing services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3.6. Oral liquid manufacturing services

5.2.2.3.6.1. Oral liquid manufacturing services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3.7. Other formulation manufacturing services

5.2.2.3.7.1. Other formulation manufacturing services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Drug Development Services

5.2.3.1. Drug Development Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Biologics Manufacturing Services

5.2.4.1. Biologics Manufacturing Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4.2. Biologics API Manufacturing Services

5.2.4.2.1. Biologics API Manufacturing Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4.3. Biologics FDF Manufacturing Services

5.2.4.3.1. Biologics FDF Manufacturing Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Pharmaceutical Contract Manufacturing Market By End-user

6.1. Introduction

6.2. Pharmaceutical Contract Manufacturing Revenue By End-user

6.2.1. Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast, By End-user, 2020-2032

6.2.2. Big Pharmaceutical Companies

6.2.2.1. Big Pharmaceutical Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Generic Pharmaceutical Companies

6.2.3.1. Generic Pharmaceutical Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Small & Medium-sized Pharmaceutical Companies

6.2.4.1. Small & Medium-sized Pharmaceutical Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5. Others

6.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. North America Pharmaceutical Contract Manufacturing Market By Country 

7.1. North America Pharmaceutical Contract Manufacturing Market Overview

7.2. U.S.

7.2.1. U.S. Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

7.2.2. U.S. Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

7.3. Canada

7.3.1. Canada Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

7.3.2. Canada Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

7.4. North America PEST Analysis

CHAPTER 8. Europe Pharmaceutical Contract Manufacturing Market By Country

8.1. Europe Pharmaceutical Contract Manufacturing Market Overview

8.2. U.K.

8.2.1. U.K. Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

8.2.2. U.K. Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

8.3. Germany

8.3.1. Germany Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

8.3.2. Germany Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

8.4. France

8.4.1. France Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

8.4.2. France Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

8.5. Spain

8.5.1. Spain Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

8.5.2. Spain Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

8.6. Rest of Europe

8.6.1. Rest of Europe Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

8.6.2. Rest of Europe Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Pharmaceutical Contract Manufacturing Market By Country

9.1. Asia Pacific Pharmaceutical Contract Manufacturing Market Overview

9.2. China

9.2.1. China Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

9.2.2. China Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.3. Japan

9.3.1. Japan Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

9.3.2. Japan Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.4. India

9.4.1. India Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

9.4.2. India Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.5. Australia

9.5.1. Australia Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

9.5.2. Australia Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.6. South Korea

9.6.1. South Korea Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

9.6.2. South Korea Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.7. Rest of Asia-Pacific

9.7.1. Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

9.7.2. Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Pharmaceutical Contract Manufacturing Market By Country

10.1. Latin America Pharmaceutical Contract Manufacturing Market Overview

10.2. Brazil

10.2.1. Brazil Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

10.2.2. Brazil Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.3. Mexico

10.3.1. Mexico Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

10.3.2. Mexico Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.4. Rest of Latin America

10.4.1. Rest of Latin America Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

10.4.2. Rest of Latin America Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Pharmaceutical Contract Manufacturing Market By Country 

11.1. Middle East & Africa Pharmaceutical Contract Manufacturing Market Overview

11.2. GCC

11.2.1. GCC Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

11.2.2. GCC Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

11.3. South Africa

11.3.1. South Africa Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

11.3.2. South Africa Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

11.4. Rest of Middle East & Africa

11.4.1. Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032

11.4.2. Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032

11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Pharmaceutical Contract Manufacturing Market

12.1. Pharmaceutical Contract Manufacturing Market Company Share Analysis

12.2. Competition Matrix

12.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment

12.2.2. New Product Launches and Product Enhancements

12.2.3. Mergers And Acquisition In Global Pharmaceutical Contract Manufacturing Market

12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. Company Profile

13.1. Lonza Group AG

13.1.1. Company Snapshot

13.1.2. Business Overview

13.1.3. Financial Overview

13.1.3.1. Revenue (USD Billion), 2022

13.1.3.2. Lonza Group AG 2022 Pharmaceutical Contract Manufacturing Business Regional Distribution

13.1.4. Product /Service and Specification

13.1.5. Recent Developments & Business Strategy

13.2. Catalent, Inc.

13.3. Thermo Fisher Scientific Inc.

13.4. Patheon N.V.

13.5. Evonik Industries AG

13.6. AbbVie Contract Manufacturing

13.7. Boehringer Ingelheim GmbH

13.8. Recipharm AB

13.9. Jubilant Life Sciences Limited

13.10. Dr. Reddy's Laboratories Ltd.